The drug, which Lilly in-licensed four years ago and is designed to inhibit a protein known as P2X7, did not meet the company ...

As pharma giant Eli Lilly builds out its direct-to-consumer care site, LillyDirect, the company has tapped virtual primary care company HealthTap to join its small lineup of independent care providers ...

Please provide your email address to receive an email when new articles are posted on . CMS recently removed fields for race and ethnicity on the Medicare enrollment form for kidney failure. Kidney ...

Industry reports reveal that British consumers are re-wearing their outfits 35% less than they did 15 years ago, with the average garment lasting only 7–10 wears[1]. Yet, there’s little discussion ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. This edge has propelled Lilly to the forefront, with ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. More than 80% of the potential $100 million in tax credits ...

Eli Lilly and Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval. The company’s shares rose as ...

Eli Lilly and Co (NYSE:LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs through artificial intelligence (AI) to treat obesity and other ...

MARSHALL, Texas--(BUSINESS WIRE)--Texas Attorney General Ken Paxton has filed a lawsuit in state court against Eli Lilly and Co., accusing the pharmaceutical giant of bribing and inducing medical ...

A new program to improve access to weight management services across the U.K. National Health Service (NHS) could benefit several obese patients. The initiative, announced Tuesday, combines government ...

S enderraCare+ redefines specialty therapy by consolidating enrollment, adherence support, and medication management into one intuitive, in real-time digital platform. It accelerates treatment ...

Shares of Eli Lilly plunged after the drug maker reported less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a blockbuster. The pill helped people ...